FundedIQ
Biotechnology

Mytos: Funding, Investors & Team (Oct 2026)

Mytos is constructing an entirely automated cell manufacturing platform geared towards the biotech sector, commencing with the drug development field.

www.mytos.bio LinkedIn London, United Kingdom 11-50 employees
Total raised
$18.0M
Rounds
1
Latest
Undisclosed round
Oct 2023

Mytos has raised $18.0M across 1 funding round on record, the most recent an undisclosed round of $18.0M announced in Oct 2023.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Mytos Company Profile and Key Stats

Total funding raised
$18.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$18.0M in Oct 2023
Employees
11-50
reported band
Headquarters
London, United Kingdom

Latest funding round on record: Oct 2023.

Mytos Funding Rounds

Date
Round
Amount
Undisclosed round
$18.0M

Mytos Founders and Leadership Team

Name
Role
Contact
Ignacio Willats
Founder
Locked

Contact details for the Mytos team: 1 of 1 has an email address on file.

Start 14-day free trial →

Mytos Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
5,368
$4.1M

Mytos' latest round of $18.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Mytos in Biotechnology and London

Companies Similar to Mytos

Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…

Series C $40.4M

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…

Series C $310M

HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…

Series A $8.0M

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

Mytos Funding FAQs

What does Mytos do?

Mytos is constructing an entirely automated cell manufacturing platform geared towards the biotech sector, commencing with the drug development field.

How much funding has Mytos raised?

Mytos has raised $18.0M across 1 round on record. The most recent is an undisclosed round of $18.0M announced in Oct 2023.

When did Mytos last raise funding?

Mytos' most recent funding round on record is an undisclosed round of $18.0M, announced in Oct 2023.

Who founded Mytos?

FundedIQ lists Ignacio Willats (Founder) at Mytos.

Where is Mytos headquartered?

Mytos is based in London, England, United Kingdom.

How many employees does Mytos have?

Mytos is in the 11-50 employee band.

How does Mytos' funding compare to other Biotechnology startups?

Mytos' latest round of $18.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Mytos Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mytos is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.